MediPharm Labs Corp.
LABS.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.83M | -8.65M | -9.84M | -10.10M | -9.70M |
| Total Depreciation and Amortization | 1.90M | 2.03M | 2.11M | 2.09M | 1.86M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.18M | 2.01M | 879.60K | -2.55M | -3.89M |
| Change in Net Operating Assets | 1.20M | 2.91M | 3.22M | 2.50M | 2.54M |
| Cash from Operations | -3.55M | -1.71M | -3.63M | -8.06M | -9.19M |
| Capital Expenditure | -112.10K | -168.20K | -337.80K | -346.80K | -349.70K |
| Sale of Property, Plant, and Equipment | 420.30K | 551.10K | 1.97M | 1.95M | 1.55M |
| Cash Acquisitions | -- | 0.00 | 0.00 | 754.10K | 754.10K |
| Divestitures | -- | 3.12M | 3.12M | 3.12M | 3.12M |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 308.20K | 3.51M | 4.76M | 5.49M | 5.08M |
| Total Debt Issued | 799.00K | 799.00K | 749.00K | 1.07M | 1.07M |
| Total Debt Repaid | -3.05M | -3.11M | -1.20M | -1.87M | -2.01M |
| Issuance of Common Stock | 14.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 391.00K | 462.00K | 531.00K | 1.28M | 576.00K |
| Cash from Financing | -1.35M | -1.35M | 51.60K | 363.10K | -267.40K |
| Foreign Exchange rate Adjustments | 3.80K | -337.50K | -279.10K | -231.10K | -240.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.59M | 106.60K | 896.10K | -2.45M | -4.62M |